RARE PRESENTATION OF HYPERPARATHYROIDISM: CASE SERIES
International Journal of Medicine and Public Healt · 15.09.2026 · 16 (3) · 3876-3879
DOI: 10.70034/ijmedph.2026.3.604 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medicine and Public Healt, online erschienen am 30.08.2026. Verfasst von Shivam Nawalkishor Asawa und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Primary hyperparathyroidism (PHPT) commonly presents with nephrolithiasis and hypercalcemia; however, several atypical manifestations remain underrecognized. We describe three uncommon clinical presentations of PHPT that highlight the diagnostic challenges and the need for a high index of suspicion. Cases: The first case involved a 50-year-old man presenting with hypokalemic paralysis. Evaluation revealed severe hypokalemia, hypercalcemia, markedly elevated parathyroid hormone (PTH), normal anion gap metabolic acidosis, alkaline urine, and bilateral medullary nephrocalcinosis, consistent with distal renal tubular acidosis (dRTA) secondary to PHPT. Sestamibi scintigraphy localized a left inferior parathyroid adenoma. The second case was a 50-yearold woman with Graves’ disease who presented with thyrotoxicosis, hypercalcemia, and elevated PTH. Imaging demonstrated a left inferior parathyroid adenoma. Following treatment of thyrotoxicosis with carbimazole, the elevated PTH became more apparent, illustrating the masking effect of hyperthyroidism on PHPT. The third case involved a 27-year-old man with MEN2A syndrome, previous pheochromocytoma, recurrent renal calculi, persistently elevated PTH despite normal serum calcium, and a positive RET Cys634Arg mutation. Histopathology after parathyroidectomy confirmed a left inferior parathyroid adenoma, representing normocalcemic PHPT.
Discussion
These cases demonstrate the diverse spectrum of PHPT beyond classical hypercalcemia. Hypercalciuria-induced nephrocalcinosis may result in distal RTA and hypokalemic paralysis. Coexisting Graves’ disease can obscure biochemical features of PHPT and reduce sestamibi scan sensitivity until euthyroidism is achieved. In MEN2A, PHPT may present in a normocalcemic state, emphasizing the importance of serial biochemical assessment and exclusion of secondary causes of elevated PTH before diagnosis.
Conclusion
Clinicians should recognize these rare manifestations of PHPT to avoid delayed diagnosis and treatment. Early identification of atypical presentations, appropriate biochemical evaluation, targeted imaging, and timely surgical intervention can significantly improve patient outcomes and prevent long-term complications.
Zitieren
APA
Asawa, S. N., Dongare, S., & Gaikwad, P. (2026). RARE PRESENTATION OF HYPERPARATHYROIDISM: CASE SERIES. International Journal of Medicine and Public Healt, 16(3), 3876-3879. https://doi.org/10.70034/ijmedph.2026.3.604
Vancouver
Asawa SN, Dongare S, Gaikwad P. RARE PRESENTATION OF HYPERPARATHYROIDISM: CASE SERIES. International Journal of Medicine and Public Healt. 2026;16(3):3876-3879. doi:10.70034/ijmedph.2026.3.604
BibTeX
@article{Asawa2026,
author = {Asawa, Shivam Nawalkishor and Dongare, Samata and Gaikwad, Prashant},
title = {RARE PRESENTATION OF HYPERPARATHYROIDISM: CASE SERIES},
journal = {International Journal of Medicine and Public Healt},
year = {2026},
volume = {16},
number = {3},
pages = {3876--3879},
doi = {10.70034/ijmedph.2026.3.604}
}
EUVIMED